Explainer on how a virus becomes a variant and whether it is necessarily a bad thing

Prof. Walter Jaoko

Professor of medical microbiology and tropical medicine, Director KAVI Institute of Clinical Research, University of Nairobi

It is important for us to remember that all viruses evolve over time. The problem with viruses is that they keep on making mistakes as they replicate. This is not unique to the virus that causes SARS-Cov-2. Viruses make copies of themselves, unlike animals which reproduce young ones. The problem is that in the process of making copies, they sometimes make a mistake and this is what is resulting into what is called a mutation. So, if they make a mistake, such that the copy is not like the original, we say that the virus has had a mutation. Thus, when you have several of this mutation, one or two mutations, we say that now you have a new variant. You are varying from the original and that is why they are called variants.

It is vital to note that variants are not necessarily a bad thing. It is not always that a variant is a bad thing because a virus can mutate to become even less infectious. The fear is when that copy, the mutation that has been created, is highly infectious. The virus can also make a mistake and the copy that it makes, the new variant, becomes less easily spread and does not cause as much severe disease as the original virus.

Our concern should be when the mistake is made and the variant becomes more easily transmissible and causes more severe disease than the original virus.

Most viral mutations have little or no impact at all in their ability to cause infection or severe disease. But depending on where that mutation occurs in the genetic material of the virus, it may have certain effects, such as:

  1. Transmission: It can be much more or less easily transmitted.
  2. In terms of severe disease, a new variant will either cause same amount of severity, less severity or our fear is that it may cause more disease.
  3. The other concern is that if we have this genetic change, a virus can escape, what we call diagnostic escape, so that making diagnosis becomes difficult.
  4. The change, the mutation, can result in the vaccines that are currently in use not being able to work against the new mutants.

With regard to COVID-19, there are multiple variants globally but the ones we call variants of interest are basically four. These include the UK variant (B.1.1.7), South African variant (B.1.351), Brazilian variant (P.1) and the Indian variant. We call them variants of concern because they have a likelihood, although not confirmed yet, of either being more easily transmitted, causing more severe disease and dodging diagnosis.

1. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQjwnueFBhChARIsAPu3YkRAyKm7oPopOdR3hdrLgKvfR7y-SXfvw7sSTCSsrRV7fETcpyo0sTEaAjehEALw_wcB

2. https://ourworldindata.org/covid-vaccinations

3. https://africacdc.org/news-item/majority-of-africans-would-take-a-safe-and-effective-covid-19-vaccine/

Get in Touch

449FansLike
0FollowersFollow
135FollowersFollow

Latest Posts

How does IPCC work?

Dr. Joseph Nzau Mutemi, one of the Lead Authors of the just-released 2021 Intergovernmental Panel on Climate Change (IPCC) report and Scientist at the...

Top scientist urges Kenya to take new approach to regulating gene editing crops

Subjecting Kenya’s gene-edited crops to the same regulations as those developed through genetic modification could unnecessarily slow their release to farmers and consumers, warned...

Press Release: Kenya Should not Regulate Genome-edited Crops as Genetically Modified Crops, Expert Says

Naivasha, 31st August, 2021-With the increase in population and demands for more food, African countries are looking for ways of boosting food production. This...

Explainer on Covid-19 Vaccines improving Surfactant Levels in the Lungs

Prof. Barack Abonyo Prof. Medical Physiology and Registrar Planning, Partnerships, Research and Innovation, Kibabii University, Kenya "Vaccines improve the level of surfactant. Vaccines are meant to...

SPECIAL GLOBAL MEDIA BRIEFING Topic: Getting your head around the vaccine data

Organized in collaboration with the Australia, New Zealand, UK, USA, Germany, Japan, Israel, Taiwan, Philippines, Thailand, Singapore, Austria, France, Indonesia and Hong Kong media...